Aminath Naifa undergoes successful liver transplantation at MIOT International despite rare blood type complication.

Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...

Activin E antibody demonstrates significant decrease in fat in obese mice by reducing visceral fat depots, which are strongly ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling ...

In the cardiology space, Dr. Mackram Eleid, interventional cardiologist at Mayo Clinic, said he is excited about improvements ...

Activin E antibody demonstrates significant decrease ... preserving muscle mass potentially reversing obesity, preventing diabetes, and improving overall cardiometabolic health.

Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the ...

90% of childhood diabetes is type 1." 5 She explains that "in type 1, because it is an attack of the autoimmune system, we can now detect the autoantibodies showing the malfunction of the immune ...